stocksPGHL
PGHL

Procter & Gamble Health Ltd.

5,603.00-64.0 (-1.13%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Procter & Gamble Health Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Procter & Gamble Health Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General4 Sept 2026
    Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company.
    The shareholders at their AGM held on September 3, 2026 approved the re-appointment of Mr. S. Madhavan as Independent Director of the Company for a period of 5 years effective November 15, 2026.
  2. AGM4 Sept 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrutinizers Report and E-Voting results for the Annual General Meeting held on September 3, 2026.
  3. AGM3 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Enclosed a summary of proceedings of the Annual General Meeting held today, viz., September 3, 2026.
  4. AGM12 Aug 2026
    59Th Annual General Meeting Of The Company
    The 59th Annual General Meeting of the Company is scheduled on Thursday, September 3, 2026 at 2:30 PM.
  5. Business Responsibility and Sustainability Reporting (BRSR)12 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    The BRSR Report for the Financial Year ended March 31, 2026 is enclosed.
  6. Reg. 34 (1) Annual Report12 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report for the Financial Year 2025-26 is enclosed for the Annual General Meeting scheduled on Thursday September 3, 2026.
  7. AGM12 Aug 2026
    Notice Calling The 59Th Annual General Meeting Of The Company.
    Enclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company, scheduled on Thursday, September 3, 2026 at 2:30 p.m.
  8. Record Date10 Aug 2026
    Record Date For Purpose Of Dividend
    Record Date for Purpose of Dividend
  9. Press Release / Media Release6 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on the Unaudited Financial Results for the Quarter ended June 30, 2026.
  10. Outcome of Board Meeting6 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting.
  11. General15 Jul 2026
    Update Regarding Company'S Annual General Meeting For The Financial Year 2025-26 And Record Date
    Dear Sir/Madam, Please find attached intimation regarding change in Company''s Annual General Meeting date for the Financial Year 2025-26 and record date for purpose of AGM/distribution ....
  12. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20183 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Dear Sir, Please find attached signed certificate for confirming compliance under Regulation 74 (5) of the SEBI (DP) Regulations, for the quarter ended June 30, 2026.
  13. General26 Jun 2026
    Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited ('The Company')
    Dear Sir, Please find attached communication in respect of deduction of TDS on the amount of final dividend income from the Company, if approved by the shareholders at the ensuing AGM.
  14. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Dear Sir, Please find attached our intimation for closure of trading window.
  15. Board Meeting26 Jun 2026
    Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6, 2026
    Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Dear Sir, In terms ....
  16. Change in Management25 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Pursuant to regulation 30 of the SEBI (LODR) Regulations, 2015, we hereby inform you regarding changes in the Senior Management Personnel of the Company shall take place effective July 1, 2026.
  17. Analyst / Investor Meet18 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    The Company has informed the Stock Exchange regarding the transcript and link to the recording of the analyst/institutional investors meeting held earlier today.
  18. Analyst / Investor Meet18 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    The Company has informed the Stock Exchange regarding the Presentation of the Analyst/Institutional investor meet scheduled to be held today.
  19. Analyst / Investor Meet4 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts ....
  20. Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Please find attached signed Annual Secretarial Compliance report for the year ended March 31, 2026

Frequently Asked Questions

Where can I download the annual report of Procter & Gamble Health Ltd.?
Annual reports of Procter & Gamble Health Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Procter & Gamble Health Ltd.?
Quarterly earnings results and presentations of Procter & Gamble Health Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Procter & Gamble Health Ltd. publish earnings call transcripts?
Earnings call transcripts of Procter & Gamble Health Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Procter & Gamble Health Ltd.?
Investor presentations and annual day presentations of Procter & Gamble Health Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Procter & Gamble Health Ltd.?
Corporate announcements and regulatory filings of Procter & Gamble Health Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Procter & Gamble Health Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Procter & Gamble Health Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Procter & Gamble Health Ltd.?
The ISIN (International Securities Identification Number) of Procter & Gamble Health Ltd. is INE199A01012. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Procter & Gamble Health Ltd. listed?
Procter & Gamble Health Ltd. is listed on NSE and BSE. The NSE symbol is PGHL and the BSE code is -.
Where can I find the shareholding pattern of Procter & Gamble Health Ltd.?
The quarterly shareholding pattern of Procter & Gamble Health Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Procter & Gamble Health Ltd. on Sharpely?
Share price data for Procter & Gamble Health Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.